Ausgabe 7/2016
Inhalt (12 Artikel)
Editorial
Improving health care systems by building ‘more Europe’
F. Antoñanzas, C. A. Juárez-Castelló, R. Rodríguez-Ibeas
Original Paper
Comparative analysis of decision maker preferences for equity/efficiency attributes in reimbursement decisions in three European countries
Petra Baji, Manuel García-Goñi, László Gulácsi, Emmanouil Mentzakis, Francesco Paolucci
Open Access
Original Paper
Exploring a new method for deriving the monetary value of a QALY
Carl Tilling, Marieke Krol, Arthur E. Attema, Aki Tsuchiya, John Brazier, Job van Exel, Werner Brouwer
Original Paper
Quality target negotiation in health care: evidence from the English NHS
Eleonora Fichera, Hugh Gravelle, Mario Pezzino, Matt Sutton
Original Paper
Switching insurer in the Irish voluntary health insurance market: determinants, incentives, and risk equalization
Conor Keegan, Conor Teljeur, Brian Turner, Steve Thomas
Open Access
Original Paper
The impact of pharmaceutical innovation on premature cancer mortality in Switzerland, 1995–2012
Frank R. Lichtenberg
Original Paper
Cost-effectiveness analysis of EGFR mutation testing in patients with non-small cell lung cancer (NSCLC) with gefitinib or carboplatin–paclitaxel
Oscar Arrieta, Pablo Anaya, Vicente Morales-Oyarvide, Laura Alejandra Ramírez-Tirado, Ana C. Polanco
Open Access
Original Paper
Overpaying morbidity adjusters in risk equalization models
R. C. van Kleef, R. C. J. A. van Vliet, W. P. M. M. van de Ven
Open Access
Original Paper
OnabotulinumtoxinA in the treatment of overactive bladder: a cost-effectiveness analysis versus best supportive care in England and Wales
Nick Freemantle, Kristin Khalaf, Clara Loveman, Sanja Stanisic, Dmitry Gultyaev, Johanna Lister, Marcus Drake